# Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma

> **NCT02927626** · EARLY_PHASE1 · COMPLETED · sponsor: **Beijing Ditan Hospital** · enrollment: 132 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Yang Yin Fu Zheng therapy
- **DRUG:** Routine medical care

## Key facts

- **NCT ID:** NCT02927626
- **Lead sponsor:** Beijing Ditan Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 132 (ACTUAL)
- **Last updated:** 2020-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02927626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02927626, "Yang Yin Fu Zheng Therapy in HBV Associated Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT02927626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*